As of April 29, 2025, Immix Biopharma (IMMX) has a market cap of $54.083 million USD. According to our data, Immix Biopharma is ranked No.8056 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $54.08 M |
-10.63%
|
Dec 31, 2024 | $60.52 M |
-68.21%
|
Dec 29, 2023 | $0.19 B |
202.18%
|
Dec 30, 2022 | $62.99 M |
-35.67%
|
Dec 31, 2021 | $97.93 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$66.78 B |
1.110 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.44 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.57 B |
-0.043 B
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$12.08 B |
0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.52 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$32.98 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$6.03 B |
-0.016 B
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.78 B |
-0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.74 B |
21.310 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.27 B |
2.591 M
|
![]() Switzerland
|
Market Cap | = | IMMX Stock Price | * | IMMX Shares Outstanding |
= | $1.95 | * | 27.72 M | |
= | $54.08 M |